sales and marketing
Nicola Miles joins MedeConnect
May 23, 2011Sales and Marketing appointment, sales and marketing
MedeConnect Healthcare Insight, the market research division of Doctors.net.uk, has strengthened its senior research team with the appointment of Nicola …
Shield Therapeutics appoints finance chief
May 16, 2011Sales and Marketing appointment, sales and marketing
Swiss specialty pharma company Shield Therapeutics has appointed Richard Jones to the newly-created role of chief financial officer. He has …
Pankaj Oza joins Idea Pharma
April 28, 2011Sales and Marketing appointment, sales and marketing
Strategic consultancy Idea Pharma has appointed Pankaj Oza to its IDEAtion delivery team. He has over 20 years’ industry experience …
Photocure appoints new chief operating officer
April 28, 2011Sales and Marketing appointment, sales and marketing
Kathleen Deardorff will join Norwegian specialist pharmaceutical company Photocure as chief operating officer on 1 May. She has over 25 …
Sten Westerberg joins BioInvent
April 26, 2011Research and Development appointment, research and development, sales and marketing
Swedish pharma company BioInvent International has appointed Sten Westerberg to the newly-created position of vice president investor relations. Sten is …
Trevor Smith to lead Takeda in Europe
April 21, 2011Research and Development, Sales and Marketing appointment, research and development, sales and marketing
Trevor Smith has been appointed chief executive of Takeda Pharmaceuticals Europe. Smith brings more than 30 years of pharmaceutical experience …
Tim Mustill and Jenny Hepburn join InterPhase
April 18, 2011Sales and Marketing appointment, sales and marketing
KnowledgePoint360 Group has appointed Tim Mustill and Jennifer Hepburn to key positions within its strategic consulting practice InterPhase. Tim has …
John Gargiulo to lead Daiichi Sankyo in the US
April 6, 2011Sales and Marketing appointment, sales and marketing
Daiichi Sankyo has appointed John Gargiulo as its president and chief executive in the US. He succeeds Joseph Pieroni who …
Kris Westelinck appointed president of Pfizer Belgium
April 5, 2011Manufacturing and Production, Research and Development, Sales and Marketing appointment, manufacturing and production, researcha and development, sales and marketing
Pfizer Belgium has promoted Kris Westelinck to the role of president. Kris was previously managing director and head of Pfizer’s …
Guy Blomfield joins Alliance Medical Group
March 21, 2011Sales and Marketing appointment, sales and marketing
European diagnostic imaging company Alliance Medical Group has appointed Guy Blomfield as group chief operating officer. He joins from from …
Richard Bergström takes DG role at EFPIA
March 18, 2011Research and Development, Sales and Marketing Brian Ager, EFPIA, Richard Bergstrom, appointment, research and development, sales and marketing
European pharma industry association EFPIA has appointed Richard Bergström as its new director general. He takes over from Brian Ager, …
Perry Evans to lead RSA Interims
March 11, 2011Business Services, Sales and Marketing Perry Evens, RSA Interims, appointment, business services, rsa, sales and marketing
UK-based life science search company RSA has appointed Perry Evans director of RSA Interims. He joined the company in 2006 …
GSK adds former Merck CFO to board
March 7, 2011Sales and Marketing GSK, GlaxoSmithKline, Judy Lewent, Stacey Cartwright, appointment, sales and marketing
GlaxoSmithKline has appointed Judy Lewent to its board as a non-executive director. She has previously served as an executive VP …
Jim McDermott to lead Quintiles Market Intelligence
March 3, 2011Sales and Marketing Jim McDermott, Quintiles, appointment, sales and marketing
Quintiles has appointed Jim McDermott as managing director of the Market Intelligence practice within its Consulting group. The practice provides …
David Redfern appointed ViiV chairman
February 28, 2011Research and Development, Sales and Marketing David Redfern, GSK, GlaxoSmithKline, Pfizer, ViiV, ViiV Healthcare, appointment, research and development, sales and marketing
David Redfern has been appointed as chairman of ViiV Healthcare, the joint GlaxoSmithKline-Pfizer venture focused on HIV.
Latest content
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes
Ofichem acquires US drug substance CDMO Kinentia
